Pill Identifier App

IL 3625 (Theophylline extended-release 300 mg)

Pill imprint IL 3625 has been identified as Theophylline extended-release 300 mg.

Theophylline is used in the treatment of asthma, acute; apnea of prematurity; asthma, maintenance and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for IL 3625 (Theophylline extended-release 300 mg)

Theophylline extended-release 300 mg IL 3625 Front
Theophylline extended-release 300 mg IL 3625 Back
Theophylline extended-release 300 mg IL 3625
Theophylline extended-release
Imprint:
IL
3625
Strength:
300 mg
Color:
White / Clear
Size:
17.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Inwood Laboratories Inc.
National Drug Code (NDC):
00258-3625
Inactive Ingredients:
ferric oxide black
butylparaben
castor oil
edetate calcium disodium
ethylcellulose
gelatin
methylparaben
pharmaceutical glaze
povidone
propylparaben
sodium lauryl sulfate
sodium propionate
starch
sugar spheres
magnesium silicate
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)